Overall survival and incidence of liver-related events in a cohort of cirrhotic patients treated with direct antiviral agents: results from a multicenter study
2019; Elsevier BV; Volume: 51; Linguagem: Inglês
10.1016/j.dld.2018.11.143
ISSN1878-3562
AutoresChiara Masetti, Massimo Marignani, Raffaella Lionetti, Umberto Vespasiani‐Gentilucci, Francesco Santopaolo, Martina Milana, Paola Begini, Chiara Taibi, Giovanni Galati, Ubaldo Visco‐Comandini, Gianpiero D’Offizi, M. Angélico,
Tópico(s)Hepatitis C virus research
ResumoBackground and aims: DAA represented a revolution in HCV management, allowing treatment in patients with advanced cirrhosis. Little is known about long-term effects on disease progression, liver-related complications and survival. Aim of our study was to investigate onset of clinical events and long-term effects of treatment on surrogate markers of fibrosis and portal hypertension in a cohort of cirrhotic patients.
Referência(s)